商品编号


P722-1



品牌


BBI Solutions



公司


BBI Solutions



公司分类


Recombinant Antigens


商品信息
NGAL is a new early
Marker
for acute kidney injury. Levels rise rapidly after renal injury and have been used in a variety of clinical situations including intensive care, emergency medicine, renal transplantation and procedures involving the use of i.v.contrast media and other nephrotoxic agents. Studies have indicated that this
Marker
has the greatest potential for the prediction and monitoring of acute renal injury following cardiac surgery. This potential has now been expanded upon, with development and commercialisation of highly specific
ELISA
testing kits.